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There is interest in understanding the mechanisms
that underlie reports that patients infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
remain PCR positive many weeks after initial infection.
The recent paper by Zhang et al. (1) suggests a poten-
tial explanation of this phenomenon by claiming that
SARS-CoV-2 RNA can integrate into the genome of
infected human cells. The authors also reanalyze RNA se-
quencing (RNA-seq) data and report that SARS-CoV-2−
host chimeric reads are present in cells and patient
tissues. Given the potential implications of this research
on the long-term impacts of COVID-19, we feel that it’s
necessary to scrutinize the evidence presented.
To determine whether SARS-CoV-2 RNA might be
retrotranscribed and integrated into the genome, the
authors conducted a proof-of-principle experiment where
human lung cells (Calu3) and kidney cells overexpress-
ing class I transposable elements andwild type (HEK293T-
L1/HEK293T) were infected with SARS-CoV-2 and
subjected to high-throughput DNA sequencing (1).
The very low frequency of identified chimeric
events (Table 1) suggests that SARS-CoV-2 integra-
tion into the host genome is unlikely. Given that the
HEK293T-L1 model increases detection of “rare inte-
gration events” and L1 can retrotranspose any poly-
adenylated cellular RNA (2) and “insertions” are found
preferentially in protein-coding exons, a bias unknown
to L1 endonuclease insertions (3), these findings are
likely spurious. Additionally, 2 of the identified 61 chime-
ric nanopore genomic DNA (gDNA) reads contain hu-
man DNA from separate chromosomes (chr1,chr22 and
chr18,chrX, respectively), suggesting a portion of chime-
ric gDNA nanopore reads have arisen due to infrequent
technical artifacts, such as base-calling software not rec-
ognizing an open-pore state between distinct molecules.
Further to this, the authors reanalyzed published
sequencing data and identified SARS-CoV-2 and hu-
man host chimeric reads in vitro and in patient RNA-seq
(1). They show that the fraction of human–viral chimeric
reads derived from negative-sense SARS-CoV-2 RNAs
is higher in patients than that observed in vitro. These
data are presented as evidence of SARS-CoV-2 inte-
gration and transcription. We question the presented
data as evidence for this phenomenon for several key
reasons. Firstly, chimeric virus−host reads are often
reported in RNA-seq (4), including SARS-CoV-2 (5).
This is partly due to complementary DNA fusions in-
troduced during the reverse transcription step of li-
brary preparation (6). Secondly, larger pools of negative-
sense SARS-CoV-2 chimeric reads may be due to dif-
ferences in RNA extraction, library preparation, and
sequencing platform. Given that negative-sense RNA
is formed during the replication of SARS-CoV-2 and
a template for messenger RNA production, significant
variation of negative-sense reads is expected in pa-
tient RNA samples. Finally, there is no evidence of
coronaviruses ever having integrated into the germ-
line of host species, as might be expected if retro-
transcription and integration occurs in nature, as
systematic screening of >750 animal species failed
to identify any coronavirus-derived endogenous vi-
ral elements (7).
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Given the inappropriate interpretation of high-throughput
sequencing methods and improper experimental design by the
authors (1), we ask for restraint about the conclusions presented by
the study. It remains unlikely that retrotranscription and integra-
tion of the SARS-CoV-2 genome in patients happens at any nota-
ble frequency, or even at all.
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Table 1. Summary of gDNA sequencing and chimeric reads identified
Accession Cell line Sequencing strategy Chimeric reads/total reads Percent of library
SRR14289057 HEK293T Illumina Enrichment 2/71,263,270 0.000003
SRR14216062 Calu3 Illumina Enrichment 3/94,274,616 0.000003
SRR14216061 Calu3 Illumina Enrichment 2/103,608,699 0.000002
SRR14163829 HEK293T-L1 Nanopore 61/12,053,919 0.0005
SRR14136237 HEK293T-L1 Illumina 8/109,004,386 0.000007
SRR14136236 HEK293T-L1 Illumina 9/178,953,858 0.000005
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